Skip to main content

Advertisement

Announcement: COVID-19 impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Articles

Editor highlights

New Content Item

Read our latest article highlights.

ICMN2020 Conference

It is with regret we announce the cancellation of the 6th International Conference on Molecular Neurodegeneration, due to the unstable situation and travel restrictions surrounding the novel Coronavirus.

Please see the ICMN website for further details.

Parkinson's disease - a series of reviews

Molecular Neurodegeneration presents a new thematic series, collating reviews on recent advances in Parkinson's Disease research. 

Guest Edited by Mark Cookson and Ted Dawson, reviews will continue to publish throughout 2020. The collection can be read here.

About Us

The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

Editors-in-Chief:

  • Guojun Bu, Mayo Clinic, USA
  • Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA

Read more

Article collections

Parkinson's Disease - A Series of Reviews

Molecular Neurodegeneration
Novel Systems and Emerging Concepts

Molecular Neurodegeneration
Basic biology and disease pathways


Advertisement

Molecular Neurodegeneration is the official journal of the BrightFocus Foundation.


Editors-in-Chief

Guojun Bu, Mayo Clinic, USA

Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA

Annual Journal Metrics

Advertisement